Industry: Machinery & Equipment
Published Date: 2025-02-25
Pages: 94 Pages
Report ld: 4221497
Request Sample
Customized Report
The global market for Cell therapy Processing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Cell therapy Processing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cell therapy Processing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cell therapy Processing in Cardiovascular Disease is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cell therapy Processing include Anthrogenesis Corp., BioNTech, Cell Ideas, Epic Sciences, Roche, FuGENE, IBC Pharmaceuticals Inc., Bluebird Bio Inc., Immodulon-Therapeutics, Immunomedics Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell therapy Processing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell therapy Processing.
The Cell therapy Processing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell therapy Processing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell therapy Processing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell therapy Processing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell therapy Processing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Products
1.2.3 Services
1.2.4 Software
1.3 Market by Application
1.3.1 Global Cell therapy Processing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cardiovascular Disease
1.3.3 Bone Repair
1.3.4 Neurological Disorders
1.3.5 Skeletal Muscle RepairImmune Diseases
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell therapy Processing Market Perspective (2020-2031)
2.2 Global Cell therapy Processing Growth Trends by Region
2.2.1 Global Cell therapy Processing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell therapy Processing Historic Market Size by Region (2020-2025)
2.2.3 Cell therapy Processing Forecasted Market Size by Region (2026-2031)
2.3 Cell therapy Processing Market Dynamics
2.3.1 Cell therapy Processing Industry Trends
2.3.2 Cell therapy Processing Market Drivers
2.3.3 Cell therapy Processing Market Challenges
2.3.4 Cell therapy Processing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell therapy Processing Players by Revenue
3.1.1 Global Top Cell therapy Processing Players by Revenue (2020-2025)
3.1.2 Global Cell therapy Processing Revenue Market Share by Players (2020-2025)
3.2 Global Cell therapy Processing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell therapy Processing Revenue
3.4 Global Cell therapy Processing Market Concentration Ratio
3.4.1 Global Cell therapy Processing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell therapy Processing Revenue in 2024
3.5 Global Key Players of Cell therapy Processing Head office and Area Served
3.6 Global Key Players of Cell therapy Processing, Product and Application
3.7 Global Key Players of Cell therapy Processing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell therapy Processing Breakdown Data by Type
4.1 Global Cell therapy Processing Historic Market Size by Type (2020-2025)
4.2 Global Cell therapy Processing Forecasted Market Size by Type (2026-2031)
5 Cell therapy Processing Breakdown Data by Application
5.1 Global Cell therapy Processing Historic Market Size by Application (2020-2025)
5.2 Global Cell therapy Processing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell therapy Processing Market Size (2020-2031)
6.2 North America Cell therapy Processing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell therapy Processing Market Size by Country (2020-2025)
6.4 North America Cell therapy Processing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell therapy Processing Market Size (2020-2031)
7.2 Europe Cell therapy Processing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell therapy Processing Market Size by Country (2020-2025)
7.4 Europe Cell therapy Processing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell therapy Processing Market Size (2020-2031)
8.2 Asia-Pacific Cell therapy Processing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell therapy Processing Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell therapy Processing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell therapy Processing Market Size (2020-2031)
9.2 Latin America Cell therapy Processing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell therapy Processing Market Size by Country (2020-2025)
9.4 Latin America Cell therapy Processing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell therapy Processing Market Size (2020-2031)
10.2 Middle East & Africa Cell therapy Processing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell therapy Processing Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell therapy Processing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Anthrogenesis Corp.
11.1.1 Anthrogenesis Corp. Company Details
11.1.2 Anthrogenesis Corp. Business Overview
11.1.3 Anthrogenesis Corp. Cell therapy Processing Introduction
11.1.4 Anthrogenesis Corp. Revenue in Cell therapy Processing Business (2020-2025)
11.1.5 Anthrogenesis Corp. Recent Development
11.2 BioNTech
11.2.1 BioNTech Company Details
11.2.2 BioNTech Business Overview
11.2.3 BioNTech Cell therapy Processing Introduction
11.2.4 BioNTech Revenue in Cell therapy Processing Business (2020-2025)
11.2.5 BioNTech Recent Development
11.3 Cell Ideas
11.3.1 Cell Ideas Company Details
11.3.2 Cell Ideas Business Overview
11.3.3 Cell Ideas Cell therapy Processing Introduction
11.3.4 Cell Ideas Revenue in Cell therapy Processing Business (2020-2025)
11.3.5 Cell Ideas Recent Development
11.4 Epic Sciences
11.4.1 Epic Sciences Company Details
11.4.2 Epic Sciences Business Overview
11.4.3 Epic Sciences Cell therapy Processing Introduction
11.4.4 Epic Sciences Revenue in Cell therapy Processing Business (2020-2025)
11.4.5 Epic Sciences Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Cell therapy Processing Introduction
11.5.4 Roche Revenue in Cell therapy Processing Business (2020-2025)
11.5.5 Roche Recent Development
11.6 FuGENE
11.6.1 FuGENE Company Details
11.6.2 FuGENE Business Overview
11.6.3 FuGENE Cell therapy Processing Introduction
11.6.4 FuGENE Revenue in Cell therapy Processing Business (2020-2025)
11.6.5 FuGENE Recent Development
11.7 IBC Pharmaceuticals Inc.
11.7.1 IBC Pharmaceuticals Inc. Company Details
11.7.2 IBC Pharmaceuticals Inc. Business Overview
11.7.3 IBC Pharmaceuticals Inc. Cell therapy Processing Introduction
11.7.4 IBC Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2020-2025)
11.7.5 IBC Pharmaceuticals Inc. Recent Development
11.8 Bluebird Bio Inc.
11.8.1 Bluebird Bio Inc. Company Details
11.8.2 Bluebird Bio Inc. Business Overview
11.8.3 Bluebird Bio Inc. Cell therapy Processing Introduction
11.8.4 Bluebird Bio Inc. Revenue in Cell therapy Processing Business (2020-2025)
11.8.5 Bluebird Bio Inc. Recent Development
11.9 Immodulon-Therapeutics
11.9.1 Immodulon-Therapeutics Company Details
11.9.2 Immodulon-Therapeutics Business Overview
11.9.3 Immodulon-Therapeutics Cell therapy Processing Introduction
11.9.4 Immodulon-Therapeutics Revenue in Cell therapy Processing Business (2020-2025)
11.9.5 Immodulon-Therapeutics Recent Development
11.10 Immunomedics Inc.
11.10.1 Immunomedics Inc. Company Details
11.10.2 Immunomedics Inc. Business Overview
11.10.3 Immunomedics Inc. Cell therapy Processing Introduction
11.10.4 Immunomedics Inc. Revenue in Cell therapy Processing Business (2020-2025)
11.10.5 Immunomedics Inc. Recent Development
11.11 Juno Therapeutics Inc.
11.11.1 Juno Therapeutics Inc. Company Details
11.11.2 Juno Therapeutics Inc. Business Overview
11.11.3 Juno Therapeutics Inc. Cell therapy Processing Introduction
11.11.4 Juno Therapeutics Inc. Revenue in Cell therapy Processing Business (2020-2025)
11.11.5 Juno Therapeutics Inc. Recent Development
11.12 Medlmmune Inc.
11.12.1 Medlmmune Inc. Company Details
11.12.2 Medlmmune Inc. Business Overview
11.12.3 Medlmmune Inc. Cell therapy Processing Introduction
11.12.4 Medlmmune Inc. Revenue in Cell therapy Processing Business (2020-2025)
11.12.5 Medlmmune Inc. Recent Development
11.13 NeoStem Oncology
11.13.1 NeoStem Oncology Company Details
11.13.2 NeoStem Oncology Business Overview
11.13.3 NeoStem Oncology Cell therapy Processing Introduction
11.13.4 NeoStem Oncology Revenue in Cell therapy Processing Business (2020-2025)
11.13.5 NeoStem Oncology Recent Development
11.14 Neurotech USA
11.14.1 Neurotech USA Company Details
11.14.2 Neurotech USA Business Overview
11.14.3 Neurotech USA Cell therapy Processing Introduction
11.14.4 Neurotech USA Revenue in Cell therapy Processing Business (2020-2025)
11.14.5 Neurotech USA Recent Development
11.15 Novartis
11.15.1 Novartis Company Details
11.15.2 Novartis Business Overview
11.15.3 Novartis Cell therapy Processing Introduction
11.15.4 Novartis Revenue in Cell therapy Processing Business (2020-2025)
11.15.5 Novartis Recent Development
11.16 Persimmune Inc.
11.16.1 Persimmune Inc. Company Details
11.16.2 Persimmune Inc. Business Overview
11.16.3 Persimmune Inc. Cell therapy Processing Introduction
11.16.4 Persimmune Inc. Revenue in Cell therapy Processing Business (2020-2025)
11.16.5 Persimmune Inc. Recent Development
11.17 Pluristem Therapeutics
11.17.1 Pluristem Therapeutics Company Details
11.17.2 Pluristem Therapeutics Business Overview
11.17.3 Pluristem Therapeutics Cell therapy Processing Introduction
11.17.4 Pluristem Therapeutics Revenue in Cell therapy Processing Business (2020-2025)
11.17.5 Pluristem Therapeutics Recent Development
11.18 BioMed Valley Discoveries Inc.
11.18.1 BioMed Valley Discoveries Inc. Company Details
11.18.2 BioMed Valley Discoveries Inc. Business Overview
11.18.3 BioMed Valley Discoveries Inc. Cell therapy Processing Introduction
11.18.4 BioMed Valley Discoveries Inc. Revenue in Cell therapy Processing Business (2020-2025)
11.18.5 BioMed Valley Discoveries Inc. Recent Development
11.19 Regeneron Pharmaceuticals Inc.
11.19.1 Regeneron Pharmaceuticals Inc. Company Details
11.19.2 Regeneron Pharmaceuticals Inc. Business Overview
11.19.3 Regeneron Pharmaceuticals Inc. Cell therapy Processing Introduction
11.19.4 Regeneron Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2020-2025)
11.19.5 Regeneron Pharmaceuticals Inc. Recent Development
11.20 UCL Business PLC.
11.20.1 UCL Business PLC. Company Details
11.20.2 UCL Business PLC. Business Overview
11.20.3 UCL Business PLC. Cell therapy Processing Introduction
11.20.4 UCL Business PLC. Revenue in Cell therapy Processing Business (2020-2025)
11.20.5 UCL Business PLC. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Cell therapy Processing was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-15
Pages: 133
USD 3950.00
(Single User License)
The global Cell therapy Processing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-28
Pages: 124
USD 2900.00
(Single User License)
The global Cell therapy Processing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-30
Pages: 153
USD 4900.00
(Single User License)
The global Cell therapy Processing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 104
USD 4250.00
(Single User License)
The global market for Cell therapy Processing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 136
USD 3950.00
(Single User License)
Market Analysis and Insights: Global Cell therapy Processing Market
Published Date: 2024-04-25
Pages: 128
USD 4900.00
(Single User License)
The global Cell therapy Processing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-11
Pages: 101
USD 2900.00
(Single User License)
The global market for Cell therapy Processing was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-15
Pages: 133
The global Cell therapy Processing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-28
Pages: 124
The global Cell therapy Processing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-30
Pages: 153
The global Cell therapy Processing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 104
The global market for Cell therapy Processing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 136
Market Analysis and Insights: Global Cell therapy Processing Market
Published: 2024-04-25
Pages: 128
The global Cell therapy Processing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-11
Pages: 101
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now